Predictors of elevated NT-pro-BNP in cardiovascular patients without acute heart failure

International Journal of Cardiology

Volumn 131, Issue 2, 2009, Pages 277-280

  Pfister, Roman ^a   Tan, Dajana ^a   Thekkanal, Jaimy ^a   Hellmich, Martin ^a   Schneider, Chistian Alfons ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cardiovascular disease; Heart failure; Natriuretic peptides; NT pro BNP

Indexed keywords

ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; FIBRINOGEN;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL EXAMINATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VALVULAR HEART DISEASE;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 57549097999     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.07.047     Document Type: Article

References (7)

1. Nieminen M.S., Brutsaert D., Dickstein K., et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27 (2006) 2725-2736
2. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
3. Januzzi J.L., van Kimmenade R., Lainchbury J., et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27 (2006) 330-337
4. Kannel W.B., D'Agostino R.B., and Belanger A.J. Update on fibrinogen as a cardiovascular risk factor. Ann Epidemiol 2 (1992) 457-466
5. Marcucci R., Gori A.M., Giannotti F., et al. Markers of hypercoagulability and inflammation predict mortality in patients with heart failure. J Thromb Haemost 4 (2006) 1017-1022
6. Androne A.S., Hryniewicz K., Hudaihed A., Mancini D., Lamanca J., and Katz S.D. Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. Am J Cardiol 93 (2004) 1254-1259
7. Arques S., Ambrosi P., Gelisse R., Luccioni R., and Habib G. Hypoalbuminemia in elderly patients with acute diastolic heart failure. J Am Coll Cardiol 42 (2003) 712-716